(Q33233370)

24 July 2017

1 reference

title

Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker (English)

1 reference

24 July 2017

0 references

1 reference

1

Daniela Berg

2 references

24 July 2017

ORCID Public Data File 2021

Olaf Riess

series ordinal

4

object named as

Olaf Riess

1 reference

24 July 2017

Helmine Hochstrasser

2

1 reference

24 July 2017

Katherine J Schweitzer

series ordinal

3

1 reference

24 July 2017

publication date

1 January 2006

1 reference

24 July 2017

published in

Neurotoxicity Research

1 reference

24 July 2017

volume

9

1 reference

24 July 2017

issue

1

1 reference

24 July 2017

page(s)

1-13

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03033302

24 July 2017

exact match

0 references

cites work

Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

1 reference

https://api.crossref.org/works/10.1007%2FBF03033302

Relationship of substantia nigra echogenicity and motor function in elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033302

Expression of the genes for the ferritin H and L subunits in rat liver and heart. Evidence for tissue-specific regulations at pre- and post-translational levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033302

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033302

Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033302

Imaging iron stores in the brain using magnetic resonance imaging

21 January 2018

1 reference

12 December 2020

Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.

1 reference

12 December 2020

Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia.

1 reference

12 December 2020

Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

1 reference

12 December 2020

Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound

1 reference

12 December 2020

Parkinson's disease, pesticides and mitochondrial dysfunction

1 reference

12 December 2020

Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease.

1 reference

12 December 2020

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

12 December 2020

Role of ceruloplasmin in cellular iron uptake

1 reference

12 December 2020

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

1 reference

12 December 2020

Roles of N-linked glycans in the endoplasmic reticulum

1 reference

12 December 2020

Aceruloplasminemia with a novel mutation associated with parkinsonism

1 reference

12 December 2020

Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein

1 reference

12 December 2020

Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging

1 reference

12 December 2020

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

1 reference

12 December 2020

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

1 reference

12 December 2020

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

1 reference

12 December 2020

Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations.

1 reference

12 December 2020

Human ferritin gene expression

1 reference

12 December 2020

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings

1 reference

12 December 2020

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

1 reference

12 December 2020

Perspectives of B-mode transcranial ultrasound

1 reference

12 December 2020

The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum

1 reference

12 December 2020

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

1 reference

12 December 2020

1 reference

12 December 2020

Association study between iron-related genes polymorphisms and Parkinson's disease

1 reference

12 December 2020

In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.

1 reference

12 December 2020

Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury

1 reference

12 December 2020

Rethinking the role of ceruloplasmin in brain iron metabolism

1 reference

12 December 2020

Magnetic resonance relaxometry in Parkinson's disease.

1 reference

12 December 2020

Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia

1 reference

12 December 2020

Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy.

1 reference

12 December 2020

Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series

1 reference

12 December 2020

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

1 reference

12 December 2020

Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2

1 reference

12 December 2020

The early diagnosis of Parkinson's disease.

1 reference

12 December 2020

1 reference

12 December 2020

Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism

1 reference

12 December 2020

Hereditary hemochromatosis since discovery of the HFE gene

1 reference

12 December 2020

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

1 reference

12 December 2020

'Unfolding' pathways in neurodegenerative disease

1 reference

12 December 2020

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease

1 reference

12 December 2020

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

1 reference

12 December 2020

The ferritins: molecular properties, iron storage function and cellular regulation

1 reference

12 December 2020

Free radicals and brain aging

1 reference

12 December 2020

Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.

1 reference

12 December 2020

Iron accumulation in the substantia nigra in rats visualized by ultrasound

1 reference

12 December 2020

Views on neurodegeneration as a basis for neuroprotective strategies.

1 reference

12 December 2020

Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress

1 reference

12 December 2020

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

1 reference

12 December 2020

Aceruloplasminemia: molecular characterization of this disorder of iron metabolism

1 reference

12 December 2020

Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease

1 reference

12 December 2020

The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration

1 reference

12 December 2020

Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor

1 reference

12 December 2020

A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload

1 reference

12 December 2020

Molecular Pathways of Neurodegeneration in Parkinson's Disease

1 reference

12 December 2020

Biochemical fundamentals of Parkinson's disease

1 reference

12 December 2020

Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice

1 reference

12 December 2020

The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred

1 reference

12 December 2020

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

12 December 2020

Computer assessment of neurodegeneration in Parkinson disease using data fusion techniques with MR images

1 reference

12 December 2020

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

12 December 2020

Screening for mutations of the IRP2 gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

1 reference

12 December 2020

The effect of age on the non-haemin iron in the human brain.

1 reference

12 December 2020

Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease.

1 reference

12 December 2020

Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

1 reference

12 December 2020

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

1 reference

12 December 2020

PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences

1 reference

12 December 2020

Oxyradicals and DNA damage

1 reference

12 December 2020

Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library

1 reference

12 December 2020

Detection of preclinical Parkinson's disease with PET

1 reference

12 December 2020

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

12 December 2020

Idiopathic Parkinson's disease and the Lewy body disorders

1 reference

12 December 2020

1 reference

12 December 2020

Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.

1 reference

12 December 2020

[Environmental factors in the etiology of Parkinson's disease]

1 reference

12 December 2020

Protein oxidation in aging and age-related diseases

1 reference

12 December 2020

Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033302

1 reference

Dimensions Publication ID

24 July 2017

1029788873

0 references

1 reference